Cryptococcal disease in the era of “test and treat”: Is there cause for concern?
View/ Open
Date
2017Author
Abassi, Mahsa
Rhein, Joshua
Meya, David B.
Boulware, David R.
Metadata
Show full item recordAbstract
Treatment of cryptococcosis requires deferred initiation of antiretroviral therapy (ART). Early ART initiation may be detrimental in the context of cryptococcal infection by increasing the risk of immune reconstitution inflammatory syndrome (IRIS). We present 3 cases where early ART initiation in the presence of unrecognized cryptococcal disease had fatal outcomes.